News & Updates

Four-drug pill beats three separate meds in difficult-to-treat hypertension
Four-drug pill beats three separate meds in difficult-to-treat hypertension
07 Sep 2024 byJairia Dela Cruz

For individuals with difficult-to-treat hypertension who are struggling with three separate medications, a single pill that combines four blood pressure (BP)-lowering drugs may help with BP control, as shown in the phase III QUADRO trial.

Four-drug pill beats three separate meds in difficult-to-treat hypertension
07 Sep 2024
SGLT-2 inhibitors may prevent dementia in adults with T2D
SGLT-2 inhibitors may prevent dementia in adults with T2D
07 Sep 2024 byStephen Padilla

Initiation of sodium-glucose cotransporter-2 (SGLT-2) inhibitors results in a 35-percent reduced risk of dementia compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in individuals with type 2 diabetes (T2D) aged 40–69 years, according to a study. In addition, greater benefits are seen with longer treatment duration.

SGLT-2 inhibitors may prevent dementia in adults with T2D
07 Sep 2024
VTE incidence similar among common SGAs
VTE incidence similar among common SGAs
05 Sep 2024

The incidence of venous thromboembolism (VTE) does not appear to significantly differ among patients treated with second-generation antipsychotics (SGAs) such as risperidone, olanzapine, or aripiprazole, results of a study have shown.

VTE incidence similar among common SGAs
05 Sep 2024
Colchicine on par with NSAID for pericarditis prevention in HFrEF, CAD
Colchicine on par with NSAID for pericarditis prevention in HFrEF, CAD
04 Sep 2024